Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators. | Cancer Drug Resist | 2021 | 35582006 | PubTator, text mining | PubMed |
| Pan-Cancer Analyses Reveal Oncogenic Role and Prognostic Value of F-Box Only Protein 22. | Front Oncol | 2021 | 35141150 | PubTator, text mining | PubMed |
| Heme in Cardiovascular Diseases: A Ubiquitous Dangerous Molecule Worthy of Vigilance. | Front Cell Dev Biol | 2021 | 35127704 | PubTator, text mining | PubMed |
| Mechanism of Action of Mesenchymal Stem Cell-Derived Exosomes in the Intervertebral Disc Degeneration Treatment and Bone Repair and Regeneration. | Front Cell Dev Biol | 2021 | 35096846 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomes Combining with Consecutive Genomics Reveal Clonal Evolution and Gene Regulatory Networks in Relapsed and Refractory Multiple Myeloma. | Front Cell Dev Biol | 2021 | 35071234 | PubTator, text mining | PubMed |
| MicroRNA-155-5p Contributes to 5-Fluorouracil Resistance Through Down-Regulating TP53INP1 in Oral Squamous Cell Carcinoma. | Front Oncol | 2021 | 35070952 | PubTator, text mining | PubMed |
| New Discoveries and Ambiguities of Nrf2 and ATF3 Signaling in Environmental Arsenic-Induced Carcinogenesis. | Antioxidants (Basel) | 2021 | 35052581 | PubTator, text mining | PubMed |
| The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention. | Antioxidants (Basel) | 2021 | 35052512 | PubTator, text mining | PubMed |
| Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. | J Adv Res | 2021 | 35024180 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiencies and Hereditary Tumors. | Int J Mol Sci | 2021 | 35008774 | PubTator, text mining | PubMed |
| Understanding Cellular Redox Homeostasis: A Challenge for Precision Medicine. | Int J Mol Sci | 2021 | 35008532 | PubTator, text mining | PubMed |
| Single-Cell Analysis Identify Transcription Factor BACH1 as a Master Regulator Gene in Vascular Cells During Aging. | Front Cell Dev Biol | 2021 | 35004685 | PubTator, text mining | PubMed |
| Ferroptosis Signaling and Regulators in Atherosclerosis. | Front Cell Dev Biol | 2021 | 34977044 | PubTator, text mining | PubMed |
| miR-23b-3p Inhibits the Oncogenicity of Colon Adenocarcinoma by Directly Targeting NFE2L3. | J Oncol | 2021 | 34966429 | PubTator, text mining | PubMed |
| Design and Synthesis of Hybrid Compounds as Epigenetic Modifiers. | Pharmaceuticals (Basel) | 2021 | 34959707 | PubTator, text mining | PubMed |
| FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway. | Front Pharmacol | 2021 | 34950036 | PubTator, text mining | PubMed |
| BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression. | Respir Res | 2021 | 34949193 | PubTator, text mining | PubMed |
| Clinical Relevance of Secreted Small Noncoding RNAs in an Embryo Implantation Potential Prediction at Morula and Blastocyst Development Stages. | Life (Basel) | 2021 | 34947859 | PubTator, text mining | PubMed |
| RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity. | Cancers (Basel) | 2021 | 34944867 | PubTator, text mining | PubMed |
| circRNAs: Insight Into Their Role in Tumor-Associated Macrophages. | Front Oncol | 2021 | 34926295 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=44